Latest Insider Transactions at View Ray, Inc. (VRAY)
This section provides a real-time view of insider transactions for View Ray, Inc. (VRAY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ViewRay, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ViewRay, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 21
2023
|
Sanket Shah SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
30,364
-7.29%
|
$0
$0.08 P/Share
|
|
Jul 21
2023
|
B Kristine Johnson Director |
SELL
Open market or private sale
|
Direct |
30,702
-19.5%
|
$0
$0.05 P/Share
|
|
Jul 21
2023
|
Karen Prange Director |
SELL
Open market or private sale
|
Direct |
37,600
-81.04%
|
$0
$0.05 P/Share
|
|
Jul 20
2023
|
Farhad Fred Ebrahimi |
SELL
Open market or private sale
|
Indirect |
8,203,610
-66.39%
|
$0
$0.06 P/Share
|
|
Jul 19
2023
|
Farhad Fred Ebrahimi |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
453,600
+3.3%
|
$907,200
$2.63 P/Share
|
|
Jul 19
2023
|
Karen Prange Director |
SELL
Open market or private sale
|
Direct |
91,866
-66.44%
|
$0
$0.08 P/Share
|
|
Jul 19
2023
|
Paul Ziegler Jr Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
169,785
-10.65%
|
$0
$0.07 P/Share
|
|
Jul 19
2023
|
Caley Castelein Director |
SELL
Open market or private sale
|
Indirect |
1,545,600
-100.0%
|
$0
$0.07 P/Share
|
|
Jul 19
2023
|
Caley Castelein Director |
SELL
Open market or private sale
|
Direct |
799,430
-52.12%
|
$0
$0.07 P/Share
|
|
Jul 18
2023
|
Farhad Fred Ebrahimi |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
49,800
+0.72%
|
$49,800
$1.5 P/Share
|
|
Jul 18
2023
|
Scott William Drake Director |
SELL
Open market or private sale
|
Direct |
2,408,747
-60.21%
|
$0
$0.06 P/Share
|
|
Jul 18
2023
|
B Kristine Johnson Director |
SELL
Open market or private sale
|
Direct |
79,622
-33.59%
|
$0
$0.07 P/Share
|
|
Jul 17
2023
|
Adam Andrew Podbelski SVP, Customer Services |
SELL
Open market or private sale
|
Direct |
89,901
-16.74%
|
$0
$0.07 P/Share
|
|
Jul 17
2023
|
Farhad Fred Ebrahimi |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
496,300
+2.84%
|
$496,300
$1.5 P/Share
|
|
Jul 15
2023
|
Adam Andrew Podbelski SVP, Customer Services |
BUY
Grant, award, or other acquisition
|
Direct |
350,000
+39.46%
|
-
|
|
Jul 15
2023
|
Sanket Shah SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
350,000
+45.65%
|
-
|
|
Jul 15
2023
|
Paul Ziegler Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,200,000
+42.96%
|
-
|
|
Jul 05
2023
|
Farhad Fred Ebrahimi |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
13,600
+0.17%
|
$13,600
$1.5 P/Share
|
|
Jun 28
2023
|
Farhad Fred Ebrahimi |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
236,100
+1.81%
|
$708,300
$3.8 P/Share
|
|
Jun 15
2023
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
116,003
-2.82%
|
$0
$0.48 P/Share
|
|
Jun 14
2023
|
Paul Ziegler Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,770
-2.18%
|
$0
$0.5 P/Share
|
|
Mar 07
2023
|
James F. Dempsey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+13.82%
|
$0
$0.75 P/Share
|
|
Mar 03
2023
|
James F. Dempsey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
42,000
-6.03%
|
$168,000
$4.13 P/Share
|
|
Mar 03
2023
|
James F. Dempsey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,000
+5.69%
|
$0
$0.75 P/Share
|
|
Mar 02
2023
|
James F. Dempsey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
39,700
-5.72%
|
$158,800
$4.12 P/Share
|
|
Mar 02
2023
|
Paul Ziegler Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,100
-4.31%
|
$72,400
$4.25 P/Share
|
|
Mar 02
2023
|
Robert S Mc Cormack SVP Gen Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
37,493
-7.09%
|
$149,972
$4.25 P/Share
|
|
Mar 02
2023
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
37,321
-0.9%
|
$149,284
$4.25 P/Share
|
|
Mar 01
2023
|
James F. Dempsey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,502
-2.4%
|
$138,008
$4.12 P/Share
|
|
Mar 01
2023
|
James F. Dempsey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,405
+10.6%
|
-
|
|
Mar 01
2023
|
William P. Burke Mr. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103,686
+22.54%
|
-
|
|
Mar 01
2023
|
Paul Ziegler Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,203
-3.19%
|
$112,812
$4.34 P/Share
|
|
Mar 01
2023
|
Paul Ziegler Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
115,207
+20.44%
|
-
|
|
Mar 01
2023
|
Robert S Mc Cormack SVP Gen Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
29,870
-2.71%
|
$119,480
$4.34 P/Share
|
|
Mar 01
2023
|
Robert S Mc Cormack SVP Gen Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
86,405
+13.4%
|
-
|
|
Mar 01
2023
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
154,948
-1.81%
|
$619,792
$4.34 P/Share
|
|
Mar 01
2023
|
Scott William Drake Director |
BUY
Grant, award, or other acquisition
|
Direct |
483,870
+10.1%
|
-
|
|
Jan 16
2023
|
William P. Burke Mr. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
252,632
+50.0%
|
-
|
|
Jan 03
2023
|
Daniel Jeffrey Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,363
+6.93%
|
$105,452
$4.4 P/Share
|
|
Jan 03
2023
|
Gail R Wilensky Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,727
+5.7%
|
$50,908
$4.4 P/Share
|
|
Jan 03
2023
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
96,546
-2.46%
|
$386,184
$4.4 P/Share
|
|
Jan 03
2023
|
Caley Castelein Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,590
+1.81%
|
$66,360
$4.4 P/Share
|
|
Jan 03
2023
|
Susan C Schnabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,909
+5.08%
|
$43,636
$4.4 P/Share
|
|
Jan 03
2023
|
Phillip M Spencer Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,727
+7.59%
|
$50,908
$4.4 P/Share
|
|
Nov 28
2022
|
Susan C Schnabel Director |
BUY
Open market or private purchase
|
Direct |
25,000
+1.85%
|
$100,000
$4.69 P/Share
|
|
Oct 24
2022
|
James F. Dempsey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,681
-5.54%
|
$150,724
$4.3 P/Share
|
|
Oct 24
2022
|
Paul Ziegler Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,391
-1.3%
|
$17,564
$4.16 P/Share
|
|
Oct 24
2022
|
Robert S Mc Cormack SVP Gen Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
32,925
-6.52%
|
$131,700
$4.16 P/Share
|
|
Oct 24
2022
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
74,032
-1.85%
|
$296,128
$4.16 P/Share
|
|
Jun 15
2022
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
116,400
-2.83%
|
$232,800
$2.69 P/Share
|